Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Change in Account Payables: 2014-2024

Historic Change in Account Payables for Editas Medicine (EDIT) over the last 11 years, with Dec 2024 value amounting to -$2.3 million.

  • Editas Medicine's Change in Account Payables fell 183.97% to -$3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.3 million, marking a year-over-year decrease of 540.25%. This contributed to the annual value of -$2.3 million for FY2024, which is 53.22% down from last year.
  • Latest data reveals that Editas Medicine reported Change in Account Payables of -$2.3 million as of FY2024, which was down 53.22% from -$1.5 million recorded in FY2023.
  • In the past 5 years, Editas Medicine's Change in Account Payables registered a high of $4.4 million during FY2022, and its lowest value of -$2.3 million during FY2024.
  • Its 3-year average for Change in Account Payables is $196,667, with a median of -$1.5 million in 2023.
  • Its Change in Account Payables has fluctuated over the past 5 years, first crashed by 233.22% in 2021, then skyrocketed by 483.49% in 2022.
  • Over the past 5 years, Editas Medicine's Change in Account Payables (Yearly) stood at $855,000 in 2020, then tumbled by 233.22% to -$1.1 million in 2021, then surged by 483.49% to $4.4 million in 2022, then crashed by 134.16% to -$1.5 million in 2023, then tumbled by 53.22% to -$2.3 million in 2024.